Shanmugham, M.; Bellanger, S.; Leo, C.H.
Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals 2023, 16, 504.
https://doi.org/10.3390/ph16040504
AMA Style
Shanmugham M, Bellanger S, Leo CH.
Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals. 2023; 16(4):504.
https://doi.org/10.3390/ph16040504
Chicago/Turabian Style
Shanmugham, Meyammai, Sophie Bellanger, and Chen Huei Leo.
2023. "Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics" Pharmaceuticals 16, no. 4: 504.
https://doi.org/10.3390/ph16040504
APA Style
Shanmugham, M., Bellanger, S., & Leo, C. H.
(2023). Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals, 16(4), 504.
https://doi.org/10.3390/ph16040504